Quantitative sudomotor axonal reflex test in patients with chemotherapy induced polyneuropathy

Key Points

• Patient assessment identified significant neurological symptoms linked to chemotherapy induced polyneuropathy, highlighting the necessity for careful monitoring.
• The quantitative sudomotor axonal reflex test provided relevant metrics for evaluating nerve function in affected individuals, facilitating targeted interventions.
• Observational analysis of patients showed a marked prevalence of symptoms, suggesting the impact of chemotherapy on neurological health over time.
• These findings may enable improved clinical strategies for managing chemotherapy induced polyneuropathy, but external validation is warranted.